SCHEMBL5078725

SCHEMBL5078725

CCC[Si](C)(C)OCC1(CO[Si](C)(C)CCC)c2ccccc2-c2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.34
CYP2C19 P33261 3/20 0.33
CYP1A2 P05177 2/20 0.33
PGR P06401 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ITGA4 P13612 1/20 0.33
CYP2C9 P11712 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
KCNQ2 O43526 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
PDK2 Q15119 6/20 0.31
MEN1 O00255 1/20 0.31
RECQL P46063 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5084660 0.94 ALDH1A1 (0.33) APEX1CYP2C19CYP1A2PGRKMT2A
SCHEMBL5082365 0.93 SMN1; SMN2 (0.31) APEX1CYP2C19CYP1A2PGRKMT2A
SCHEMBL5081723 0.91 PDK2 (0.33) CYP2C19CYP2C9NPSR1PDK2
SCHEMBL5082307 0.90 CYP2C19 (0.36) APEX1CYP2C19CYP1A2PGRKMT2A
SCHEMBL5085385 0.88 PDK2 (0.40) KCNQ2CYP3A4ALOX15TSHRPDK2
SCHEMBL5078647 0.86 APEX1 (0.36) APEX1CYP2C19CYP1A2PGRKMT2A
SCHEMBL5082272 0.85 CYP2C9 (0.33) CYP2C19CYP1A2KMT2AALDH1A1MAPT
SCHEMBL5078657 0.84 CYP2C9 (0.33) CYP2C19KMT2ACYP2C9NPSR1SMN1; SMN2
SCHEMBL5084634 0.83 CYP2C9 (0.34) CYP2C19CYP1A2KMT2ACYP2C9NPSR1
SCHEMBL5082316 0.83 APEX1 (0.35) APEX1CYP1A2KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142146-A1 Catalyst for olefin polymerization and use of the same CHINA PETROLEUM & CHEMICAL CORPORATION 2006-06-29 US claimed
US-6822109-B2 TRIHYDROCARBYLSILYLATION; ADDITION POLYMERIZATION OF OLEFINS CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2004-11-23 US claimed
US-20040106814-A1 Silicon ether compound, a method for the preparation thereof and use thereof BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2004-06-03 US claimed
US-7323431-B2 Catalyst for olefin polymerization and use of the same CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-01-29 US disclosed
US-20060142146-A1 Catalyst for olefin polymerization and use of the same CHINA PETROLEUM & CHEMICAL CORPORATION 2006-06-29 US disclosed
US-6822109-B2 TRIHYDROCARBYLSILYLATION; ADDITION POLYMERIZATION OF OLEFINS CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2004-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106814-A1 Silicon ether compound, a method for the preparation thereof and use thereof SIK1, CDK20, SGMS1 APEX1 1975/4885CYP2C19 588/4885CYP1A2 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.